Tag: GW Pharmaceuticals

May 16, 2019

Marijuana Stocks by Industry

Investors have seen a rush in cannabis investment lead to a division of marijuana stocks by industry. Here's what the...
May 15, 2019

The Future of Medical Cannabis: Cannabinoid-based Pharmaceuticals

One of the most promising cannabis markets of the future can be found in the healthcare industry as pharmaceutical companies...
January 22, 2019

FSD Pharma Strengthens Drug Development with GW Executive

Rupert Haynes and Raza Bokhari of FSD Pharma discuss the company’s pharma initiative, synthetic cannabinoids and extraction methods.
November 26, 2018

FSD PHARMA Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer

FSD Pharma Inc, (CSE:HUGE) announced today the appointment of Rupert Haynes as Chief Executive Officer. Mr. Haynes is a highly...
November 9, 2018

Cannabis Weekly Round-Up: Jeff Sessions Steps Down

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
October 5, 2018

GW Pharmaceuticals Announces the Closing of Public Offering of ADSs

GW Pharmaceuticals (Nasdaq:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform,...
September 27, 2018

GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce the DEA has Rescheduled EPIDIOLEX (cannabidiol) Oral Solution to Schedule V

GW Pharmaceuticals (Nasdaq:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform,...